800
Participants
Start Date
January 1, 2018
Primary Completion Date
December 8, 2024
Study Completion Date
December 8, 2024
blood sample to analyse AMH level on the serum
Evaluation of MS/NMOSD inflammatory activity on the serum AMH level (ng/ml)
CHU Clermont-Ferrand, Clermont-Ferrand
CHU Amiens, Amiens
CHU Besancon, Besançon
CHU Bordeaux, Bordeaux
CHU Caen, Caen
AP-HP - Créteil, Créteil
CHU Dijon, Dijon
CHU Grenoble, Grenoble
CHU Lille, Lille
CHU Limoges, Limoges
Hospices Civils de Lyon, Lyon
AP-HM, Marseille
CHU Montpellier, Montpellier
CHU Nancy, Nancy
CHU Nantes, Nantes
CHU Nice, Nice
CHU Nîmes, Nîmes
Hôpital de la Pitié-Salpêtrière, Paris
Hôpital Fondation Rothschild, Paris
Hôpital Saint Antoine, Paris
CHI Poissy- Saint-Germain-en-Laye, Poissy
CHU Poitiers, Poitiers
CHU Rennes, Rennes
CHU Strasbourg, Strasbourg
CHU Toulouse, Toulouse
CHU Tours, Tours
CHU Fort-de-France, Fort-de-France
Observatoire Français de la sclérose en plaques (OFSEP)
UNKNOWN
Roche Diagnostic Ltd.
INDUSTRY
ARSEP foundation
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER